Your browser is no longer supported. Please, upgrade your browser.
ENDP [NASD]
Endo International plc
Index- P/E- EPS (ttm)-0.47 Insider Own1.16% Shs Outstand230.04M Perf Week-26.26%
Market Cap1.95B Forward P/E3.24 EPS next Y2.23 Insider Trans0.00% Shs Float227.03M Perf Month-0.69%
Income-102.30M PEG- EPS next Q0.52 Inst Own84.80% Short Float8.64% Perf Quarter34.14%
Sales2.91B P/S0.67 EPS this Y62.60% Inst Trans2.48% Short Ratio4.53 Perf Half Y138.61%
Book/sh-3.40 P/B- EPS next Y-0.53% ROA-1.70% Target Price6.91 Perf Year26.62%
Cash/sh6.21 P/C1.16 EPS next 5Y-12.37% ROE20.30% 52W Range2.08 - 10.89 Perf YTD0.70%
Dividend- P/FCF6.48 EPS past 5Y-43.10% ROI2.70% 52W High-33.61% Beta1.42
Dividend %- Quick Ratio1.90 Sales past 5Y4.10% Gross Margin49.30% 52W Low247.60% ATR0.67
Employees3172 Current Ratio2.20 Sales Q/Q-13.00% Oper. Margin10.90% RSI (14)34.74 Volatility9.73% 7.37%
OptionableYes Debt/Eq- EPS Q/Q-64.00% Profit Margin-5.40% Rel Volume1.25 Prev Close7.51
ShortableYes LT Debt/Eq- EarningsFeb 25 AMC Payout- Avg Volume4.33M Price7.23
Recom2.90 SMA20-21.46% SMA50-7.46% SMA20046.63% Volume5,397,240 Change-3.73%
Jul-27-20Initiated Goldman Sell $3
Apr-24-20Initiated Citigroup Buy $7
Jan-03-20Upgrade Piper Jaffray Neutral → Overweight $5 → $7
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jun-17-19Downgrade Citigroup Buy → Neutral
Jun-11-19Initiated Barclays Equal Weight
May-13-19Downgrade JP Morgan Neutral → Underweight
Mar-20-19Initiated SunTrust Buy
Mar-05-19Downgrade SVB Leerink Outperform → Mkt Perform
Nov-09-18Upgrade Canaccord Genuity Hold → Buy $16 → $20
Sep-11-18Upgrade Goldman Sell → Neutral
Aug-13-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Aug-09-18Reiterated Stifel Hold $10 → $17
Jun-27-18Upgrade Citigroup Neutral → Buy
Apr-04-18Downgrade Mizuho Buy → Neutral $12 → $7
Feb-28-18Downgrade Gabelli & Co Buy → Hold
Feb-14-18Initiated B. Riley FBR, Inc. Buy $10
Jan-03-18Reiterated Mizuho Buy $14 → $12
Jan-03-18Initiated Leerink Partners Outperform $12
Dec-12-17Initiated Guggenheim Neutral $8.50
Feb-26-21 12:31PM  
12:09PM  
Feb-25-21 04:30PM  
Feb-24-21 10:17AM  
Feb-17-21 05:00PM  
05:00PM  
04:15PM  
Feb-09-21 12:10PM  
Feb-02-21 06:00AM  
Jan-26-21 05:00PM  
Jan-11-21 12:00PM  
Jan-06-21 10:13AM  
Jan-05-21 08:36AM  
08:36AM  
08:31AM  
08:15AM  
08:00AM  
Jan-04-21 09:00AM  
Dec-18-20 05:00PM  
05:00PM  
Dec-16-20 03:19PM  
01:57PM  
Dec-10-20 12:01AM  
Dec-05-20 11:32AM  
Dec-02-20 09:47AM  
09:09AM  
08:45AM  
Nov-19-20 04:41PM  
Nov-18-20 05:00PM  
05:00PM  
09:35AM  
08:00AM  
Nov-17-20 06:00AM  
Nov-10-20 05:46PM  
Nov-06-20 01:26PM  
10:38AM  
Nov-05-20 07:40PM  
04:49PM  
07:30AM  
Nov-04-20 12:08PM  
Nov-03-20 08:26AM  
Nov-02-20 07:00AM  
Oct-29-20 12:34PM  
Oct-23-20 12:10PM  
Oct-22-20 04:30PM  
07:00AM  
Oct-20-20 10:40AM  
Oct-19-20 06:51PM  
04:25PM  
01:50PM  
01:15PM  
10:05AM  
07:30AM  
07:30AM  
Oct-07-20 08:31AM  
Oct-06-20 05:06PM  
04:26PM  
02:34PM  
02:34PM  
Oct-01-20 05:38PM  
05:38PM  
Sep-28-20 04:41PM  
08:54AM  
Sep-25-20 06:18PM  
04:12PM  
12:09PM  
09:25AM  
09:19AM  
07:35AM  
07:00AM  
07:00AM  
Sep-24-20 07:00AM  
Sep-08-20 05:30PM  
04:02PM  
11:35AM  
Sep-04-20 11:31AM  
Aug-21-20 08:30PM  
08:30PM  
Aug-18-20 05:47PM  
04:20PM  
02:15PM  
12:01PM  
12:00PM  
11:10AM  
Aug-17-20 05:20PM  
03:53PM  
03:00PM  
02:55PM  
02:00PM  
01:00PM  
12:30PM  
11:56AM  
09:57AM  
08:00AM  
06:20AM  
Aug-16-20 03:10PM  
11:51AM  
10:49AM  
Aug-15-20 02:36PM  
Aug-14-20 02:42PM  
Endo International plc manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; TESTOPEL for TRT in conditions associated with a deficiency or absence of endogenous testosterone; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; VOLTAREN gel for the relief of joint pain of osteoarthritis; LIDODERM for the relief of pain; TESTOPEL, an implantable pellet indicated for TRT in conditions; EDEX to treat erectile dysfunction; and LIDODERM a topical patch product containing lidocaine. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays; and products for the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, and oncology. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Endo International plc10% OwnerDec 02Buy88.507,344,955650,028,518100Dec 08 09:21 AM